Important glaucoma-based research led by investigators at NYU Grossman School of Medicine reveals that a chemical known to protect nerve cells actually slows down the…
How can we make cancer-focused clinical trials more inclusive while also raising the quality of overall research? That sounds like a win-win value proposition. But…
Organicell Regenerative Medicine, Inc. (OTCMKTS: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, today announced that it has entered into an…
A group of dedicated physicians recently came together to send an open letter to the medical journal JAMA. Their purpose: to declare that the recent…
Vaccines out of China were produced, and approved, rapidly but actual transparency into true efficacy has been more challenging but recently the results of a…
The University of Sydney, Technovalia, and Vax4COVID recently shared their ethics committee has authorized the greenlight of a Phase 1 clinical trial of the COVIGEN COVID-19…
The nation’s top doctor went on the record recently that just because an individual is fully vaccinated with one of the COVID-19 vaccines authorized under…
In a highly targeted, focused effort in regenerative medicine, two University of Arkansas researchers received a $480,000 National Science Foundation grant to investigate how engineered coatings…
The National Institutes of Health (NIH) has awarded Clemson University with $10.6 million to establish the Center of Biomedical Research Excellence (COBRE) in Human Genetics…
An oral IL-17 inhibitor drug developed originally at Manchester University was transferred to a spinoff called C4X Discovery Holdings back in 2007. Most recently, the company achieved…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
